Scienture Holdings Inc (SCNX) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Scienture Holdings Inc   (NASDAQ: SCNX)


Scienture Holdings Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Scienture Holdings Inc's ROI in the second quarter of 2026?
Scienture Holdings Inc recorded a cumulative net loss of $-38 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -44.46%.

Within the Healthcare sector 197 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3113 to 3672.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -13.48 % 13.95 % 66.56 % 251.28 % 950.97 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 85 78 81 97 96
Return On Investment (TTM) -44.46 % -47.39 % -44.36 % -20.38 % -20.4 %
SCNX's Overall Ranking # 3672 # 3113 # 3253 # 2877 # 2714
Seq. Investment Change TTM -3.33 % -5.62 % -7.2 % 2.19 % 27.32 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -38 -42 -42 -21 -20




Return On Investment SCNX's Ranking
Within: No.
Industry # 68
Sector # 198
Overall # 3672

Return On Investment Statistics
High Average Low
309.72 %
-174.44 %
-3254.32 %
(Jun 30 2018)   (Dec 31 2016)







Financial Statements
Scienture Holdings Inc's II. Quarter Investments $ 85 Millions SCNX's Balance sheet
Scienture Holdings Inc's II. Quarter Income $ -3 Millions Quarterly SCNX's Income Statement
SCNX's Income by Division See SCNX's Income by Division


SCNX Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 81 97 1 1 5
Y / Y Investment Growth -15.99 % 16987.58 % -50.36 % -76.39 % -45.92 %
Net Income in Millions -42 9 -18 -4 -5
Y / Y Net Income Growth - - - - -
Annual Return On Investment -50.97 % 9.35 % -3145.06 % -342.08 % -109.83 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SCNX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SCNX's Competitors
Subscribers only: Roi for Scienture Holdings Inc's Suppliers
Subscribers only: Return On Investment for SCNX's Customers

Other Ratios
SCNX's Roa SCNX's Inventory Turnover Ratio SCNX's Growth Rates SCNX's Dividend Statistics
SCNX's Profitability Ratios SCNX's Asset Turnover Ratio SCNX's Dividend Growth
SCNX's Roe SCNX's Valuation Ratios SCNX's Financial Strength Ratios SCNX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI


Date modified: 2026-09-26T07:15:10+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.